4//SEC Filing
Fore Henrietta 4
Accession 0001179110-17-011429
CIK 0001583107other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 6:33 PM ET
Size
4.9 KB
Accession
0001179110-17-011429
Insider Transaction Report
Form 4
Fore Henrietta
Director
Transactions
- Purchase
Ordinary Shares
2017-08-11$23.99/sh+6,000$143,932→ 24,000 total
Footnotes (1)
- [F1]Represents the weighted average purchase price per share for the open market purchase on August 11, 2017. The shares were purchased at prices ranging from $23.98 to $23.989 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001503774
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 6:33 PM ET
- Size
- 4.9 KB